Vancouver, British Columbia--(Newsfile Corp. - December 1, 2025) - BioMark Diagnostics Inc. (CSE: BUX) (FSE: 20B) (OTCQB: BMKDF) ("BioMark"), a leading developer of liquid biopsy technologies for ...
Renovaro Inc. announces funding approval for LUMINA, a platform detecting minimal residual disease in lung cancer using multi-omics and AI. Renovaro Inc. announced that its subsidiary, RenovaroCube, ...
Core Director: Rui-Ming Liu, Ph.D. Idiopathic pulmonary fibrosis (IPF) is a most enigmatic fatal lung disorder. Although significant progress has been made in our understanding of IPF pathogenesis, ...
Public Health Relevance Statement: Idiopathic Pulmonary Fibrosis (IPF) is fatal lung disorder for which no U.S. FDA-approved drugs currently exist. This project will lead to the development of novel ...
Significant research funding in the form of a five-year, $12.1 million U19 Grant from the National Institutes of Health (NIH) has been awarded to a collaboration of research teams co-led by ...
This project is not being offered for the current term. Please check back next semester for updates. The research of our laboratory is focused on lung embryonic specification and especially lung ...
SEOUL, South Korea, Nov. 11, 2025 /PRNewswire/ -- Coreline Soft, a global leader in AI-powered chest diagnostic solutions, today announced its selection as the exclusive artificial intelligence ...
"Lung cancer remains a devastating disease, and Prof. Yarden's approach to tackling drug resistance with bispecific antibodies is precisely the kind of bold, out-of-the-box science that can transform ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results